PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to ... PR Web (press release) GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022”. The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more ... |